Internal Medicine, Hematology & Oncology · St Louis, MO
NPI
1659480242
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3660 Vista
St Louis, MO, 63110
Phone (314) 577-8854
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
442 services
Medicare patients, 2024
122
Average age 69
Drug cost, 2024
$2.3M
810 prescriptions
Company payments, 2024
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John M Richart was code 99233 (hospital e&m - subsequent), 106 times for 23 patients. In total John M Richart billed 442 services in 12 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 106 | 23 | $91.91 | $9,743 |
| 99214 Office E&M - Established | Facility | 101 | 37 | $70.07 | $7,077 |
| 99213 Office E&M - Established | Facility | 54 | 36 | $47.75 | $2,579 |
| 99215 Office E&M - Established | Facility | 53 | 29 | $106.14 | $5,626 |
| 99214 Office E&M - Established | Office | 32 | 13 | $71.53 | $2,289 |
| 99213 Office E&M - Established | Office | 19 | 12 | $44.85 | $852 |
| 99223 Hospital E&M - Initial | Facility | 13 | 12 | $136.62 | $1,776 |
By year: 2022 $115K for 6,768 services; 2023 $57K for 1,556 services; 2024 $34K for 442 services.
Medicare prescription drug claims, 2024
In 2024, the drug John M Richart prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 44 prescriptions and refills. In total John M Richart wrote 810 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 44 | 64 | Under 11 | $1,652 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 36 | 59 | 11 | $89.86 |
| Morphine Sulfate Er Morphine Sulfate | 35 | 35 | Under 11 | $970 |
| Oxycodone Hcl Generic | 32 | 32 | 11 | $792 |
| Venclexta Venetoclax | 30 | 30 | Under 11 | $106K |
| Ondansetron Hcl Generic | 28 | 28 | Under 11 | $91.04 |
| Potassium Chloride Generic | 28 | 41 | Under 11 | $223 |
| Levothyroxine Sodium Generic | 26 | 54 | Under 11 | $464 |
| Levetiracetam Generic | 19 | 19 | Under 11 | $191 |
| Hydroxyurea Generic | 18 | 28 | Under 11 | $214 |
| Prochlorperazine Maleate Generic | 18 | 18 | 11 | $318 |
| Posaconazole Generic | 18 | 18 | Under 11 | $13K |
| Xarelto Rivaroxaban | 17 | 27 | Under 11 | $15K |
| Gengraf Cyclosporine, Modified | 16 | 18 | Under 11 | $1,357 |
| Gabapentin Generic | 16 | 16 | Under 11 | $172 |
Brand drugs: - claims; generic drugs: 626 claims; opioid claims: 106.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid John M Richart $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.